| COVID-19 |
1 |
1 |
| Stem Cell Research and Therapy |
0 |
0.83 |
| Transplantation |
0 |
0.81 |
| Lung |
0 |
0.68 |
| Organ Transplantation |
0 |
0.62 |
| Allograft |
0 |
0.6 |
| Transplant Program |
0 |
0.56 |
| Lung Transplantation |
0 |
0.99 |
| Acute Respiratory Distress Syndrome |
0 |
0.17 |
| Immunization |
0 |
0.12 |
| Organ Procurement and Transplantation Network |
0 |
0.1 |
| Allograft Rejection |
0 |
0.09 |
| Severe Acute Respiratory Syndrome |
0 |
0.08 |
| CT Scan |
0 |
0.06 |
| Immunocompromise |
0 |
0.05 |
| Pneumonia |
0 |
0.05 |
| Vaccines |
0 |
0.05 |
| Hospital |
0 |
0.04 |
| Biopsy |
0 |
0.03 |
| Chronic Rejection |
0 |
0.03 |
| Organ Procurement |
0 |
0.03 |
| Pandemic |
0 |
0.03 |
| Viral Infection |
0 |
0.03 |
| Wound Management |
0 |
0.02 |
| Bronchoalveolar Lavage |
0 |
0.01 |
| Corticosteroids |
0 |
0.01 |
| COVID-19 Testing |
0 |
0.01 |
| Forced Expiratory Volume in One Second |
0 |
0.01 |
| Injury |
0 |
0.01 |
| Lymphocytes |
0 |
0.01 |
| Prognosis |
0 |
0.01 |
| Scan |
0 |
0.01 |
| Texas |
0 |
0.01 |
| Thorax |
0 |
0.01 |
| X-ray |
0 |
0.01 |